Phagocytic Shuttle Method for CNS Debris Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective means to monitor and analyze central nervous system (CNS)-derived debris in recirculating phagocytes for real-time data on brain health and neurological conditions, limiting the ability to detect early changes or responses to treatments.
Innovation Solution
A phagocytic shuttle method (PSM) is developed to analyze CNS-derived debris by isolating and analyzing phagocytes that re-enter the bloodstream from the CNS, using techniques like flow cytometry, ELISA, and fluorescent staining to detect biomarkers such as GFAP and Tau, allowing for single-cell analysis and whole blood sample analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If invasive imaging or biopsy methods are used to monitor CNS processes, then measurement precision is improved, but device complexity and patient risk increase
Solution Approach 1:
The patent extracts CNS-derived debris from recirculating phagocytes in peripheral blood samples, allowing indirect monitoring of CNS processes without invasive procedures. The method isolates and analyzes debris particles contained within phagocytes that have traversed the blood-brain barrier, thereby obtaining CNS information from easily accessible peripheral blood rather than through complex imaging or biopsy procedures.
Solution Approach 2:
The patent uses recirculating phagocytes as intermediary carriers that transport CNS-derived debris from the brain to peripheral circulation. These phagocytes serve as natural mediators, bringing information from the inaccessible CNS to accessible peripheral blood, enabling indirect detection without direct CNS intervention.
2Device complexity
If current methods are used to detect CNS-derived debris, then device complexity is reduced, but measurement precision and real-time monitoring capability deteriorate
Solution Approach 1:
The patent replaces complex mechanical imaging systems or biopsy procedures with biochemical detection methods. Instead of using sophisticated imaging equipment to directly visualize CNS processes, the method employs biochemical assays to detect and quantify CNS-derived debris particles within recirculating phagocytes, substituting mechanical complexity with biochemical simplicity while enhancing detection precision.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables close to real-time monitoring of CNS processes, providing data on brain health and neurological conditions, and aiding in the detection of changes associated with diseases or treatment responses without the need for invasive imaging or biopsies.
Implementation Method 1
when tissue damage occurs, it incites inflammation, which usually aids in wound healing. For example, one of the normal functions of inflammation is to recruit phagocytes to clear away the cellular debris
Implementation Method 2
using techniques like flow cytometry, ELISA, and fluorescent staining to detect biomarkers
Implementation Method 3
using techniques like flow cytometry, ELISA, and fluorescent staining to detect biomarkers
Implementation Method 4
using techniques like flow cytometry, ELISA, and fluorescent staining to detect biomarkers such as GFAP and Tau
Data Source
AI summary
Methods for preparing neural-derived compounds, e.g., the debris such as peptides, nucleic acids, or other compounds that would only normally be found in brain or CNS tissue, from circulating phagocytes. The methods herein may feature extracting lysate from circulating phagocytes obtained from outside central nervous system (CNS) tissue, producing a fraction of the lysate comprising CNS-derived compounds, and analyzing the CNS-derived compounds in the fraction.